Case Numbers and Process Quality in Breast Surgery in Germany

Similar documents
Standard 4.6: The Importance of CAP Protocols and Understanding Synoptic Reporting

Breast Cancer Services in Germany

BREAST CANCER SITE STUDY REPORT By Robert O. Maganini, M.D., F.A.C.S. Breast Surgeon, Alexian Brothers Medical Group

EUSOMA GUIDELINES Prof Robert Mansel President Elect EUSOMA Cardiff University. mansel

the EUROPEAN COMMISSION INITIATIVE

BreastScreen Victoria Annual Statistical Report

CLINICAL-PATHOLOGICAL INDICATORS OF AN OPPORTUNISTIC BREAST CANCER SCREENING: A POPULATION-BASED STUDY

BreastScreen Victoria Annual Statistical Report

ECIBC overview. Donata LERDA Healthcare Quality Team leader

European Commission Initiative on Breast Cancer (ECIBC) MEETING OF MONITORING SUBGROUP Ispra, 14 September 2016 (10:00-17:00) Minutes

BreastScreen Victoria Annual Statistical Report

Supplementary Online Content

Slide 1. Slide 2. Slide 3 History of Nurse Navigator

Futura. Cancer cover guide

OST saves lives it s official! OST a key to HIV prevention Opioid Substitution Treatment in Germany A Story of Success

How does Active Mobility. Dr. Ute Winkler, Federal Ministry of Health, Germany

Supporting Information

The 2003 Council Recommendation on Cancer Screening and the European Initiative on Breast Cancer

One Breast Cancer Annual Report

Minimizing Errors in Diagnostic Pathology

PRINCIPLES OF ONCOLOGY FOR CANCER REGISTRY PROFESSIONALS SYLLABUS AND OBJECTIVES

Northumberland, Tyne and Wear NHS Foundation Trust. Board of Directors Meeting

Educational Goals and Objectives for Rotations on: Breast, Wound and Plastic Surgery

BREASTSCREEN AOTEAROA INDEPENDENT MONITORING REPORT:

ECIBC the EUROPEAN COMMISSION INITIATIVE on BREAST CANCER. Livia Giordano GDG Member CPO Piemonte - ITALY

Introduction 1. Executive Summary 5

Greater Baltimore Medical Center Sandra & Malcolm Berman Cancer Institute

The EBC Council Manifesto on optimal breast pathology

!"#$ Oncology Outcomes Report

Breast cancer screening programme: France. Dr. Rosemary Ancelle-Park Department of health Office for chronic diseases

Surgical Therapy: Sentinel Node Biopsy and Breast Conservation

A European Quality Assurance Scheme for Breast Cancer Services - updates Joint Research Centre

Annual Report 2015 of the Certified Breast Cancer Centres (BCCs)

Analyzing Health Technology Assessment (HTA) Decisions in Oncology

BreastScreen Victoria Annual Statistical Report

Case Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity.

Understanding Your Pathology Report

Basement membrane in lobule.

The New CP 3 R Application And Revisions To Standard 4.6 Integration Of The NCDB With The Accreditation Process

Placing Donation within End-of-Life Care in Intensive Care in Europe

Folate Status of the Population in the European Community and Strategies for Change

Faster Cancer Treatment Indicators: Use cases

GENERAL COMMENTS. The Task Force Process Should be Fully Open, Balanced and Transparent

Alcohol policymaking in the context of a larger Europe

Safety and Transparency Action Plan for Consumer Protection in the Feed Chain

Bladder cancer: National Collaborating Centre for Cancer. diagnosis and management. Clinical Guideline. 28 July 2014.

Mammographic features and correlation with biopsy findings using 11-gauge stereotactic vacuum-assisted breast biopsy (SVABB)

Rare Urological Cancers Urological Cancers SSCRG

Automatic Extraction of Synoptic Data. George Cernile Artificial Intelligence in Medicine AIM

Recall and Cancer Detection Rates for Screening Mammography: Finding the Sweet Spot

MBP AP 3 Core Curriculum

National Breast Cancer Audit next steps. Martin Lee

2017 San Antonio Breast Cancer Symposium: Local Therapy Highlights

EUROPA DONNA Advocates Guide to the ECIBC European Commission Initiative on Breast Cancer

Concordance with Breast Cancer Pathology Reporting Practice Guidelines

Ibrutinib (chronic lymphocytic leukaemia)

Cancer in Australia: Actual incidence data from 1991 to 2009 and mortality data from 1991 to 2010 with projections to 2012

CONTENTS NOTE TO THE READER...1 LIST OF PARTICIPANTS...3

Bruno CUTULI Policlinico Courlancy REIMS. WORKSHOP SULL IRRADIAZIONE MAMMARIA IPOFRAZIONATA Il carcinoma duttale in situ

Audit. Public Health Monitoring Report on 2006 Data. National Breast & Ovarian Cancer Centre and Royal Australasian College of Surgeons.

Idelalisib Benefit assessment according to 35a Social Code Book V 1

RUTGERS CANCER INSTITUTE OF NEW JERSEY - ROBERT WOOD JOHNSON MEDICAL SCHOOL INTERDISCIPLINARY BREAST SURGERY FELLOWSHIP CORE EDUCATIONAL OBJECTIVES

Development of guidelinebased quality indicators

GASTRIC MEASURE SPECIFICATIONS

Commission on Cancer Updates

Ascertaining and reporting interval cancers in BreastScreen Aotearoa: A protocol NATIONAL SCREENING UNIT (NSU) MINISTRY OF HEALTH

Guideline for the Diagnosis of Breast Cancer

Cancer Center Dashboard

Short Term Cancer Risk

COLORECTAL CARCINOMA

Genomic Health. Kim Popovits, Chairman, CEO and President

Cancer survival and prevalence in Tasmania

Laparoscopic right-sided colon resection for colon cancer has the control group so far been chosen correctly?

Radiation and DCIS. The 16 th Annual Conference on A Multidisciplinary Approach to Comprehensive Breast Care and Imaging

Involvement of people affected

Chapter 13 Cancer of the Female Breast

SSO-ASTRO Consensus Guidance Margins for Breast-Conserving Surgery with Whole Breast Irradiation in Stage I and II Invasive Breast Cancer

Mammography. What is Mammography? What are some common uses of the procedure?

Evaluation of Abstracting: Cancers Diagnosed in MCSS Quality Control Report 2005:2. Elaine N. Collins, M.A., R.H.I.A., C.T.R

Acute Care of Older Surgical Patients. Dr Shane O Hanlon Consultant Geriatrician St Vincent s University Hospital IHFM 8 th Nov 2017

Question: If in a particular case, there is doubt about the correct T, N or M category, what do you do?

Minimally Invasive Esophagectomy: OVERRATED!!! Sagar Damle UCHSC December 11, 2006

Resection Margins in Breast Conserving Surgery. Alberto Costa, MD Canton Ticino Breast Unit Lugano, Switzerland

Commissioner Tonio Borg delivers a speech at the launch of the European Cancer Patients' Bill of Rights

K. M. Sorensen Utah State University, Logan, Utah

NCCN TRENDS DEMOGRAPHICS. Results: September 2012 DUCTAL CARCINOMA IN SITU (DCIS) Distribution of Respondent Types (n = 1,778) Page 1

Mammo-50 Eligibility Queries

Soft Tissue Sarcoma: What is best practice?

Programme Report

Annual Report 2017 of the Certified Neuro-oncology Cancer Centres

LCA Lung Clinical Forum. 21 st October 2014

Impact of digitalization of mammographic units on average glandular doses in the Flemish Breast Cancer Screening Program

Problems in staging breast carcinoma

Ductal Carcinoma-in-Situ: New Concepts and Controversies

The Current Landscape of Nurse Navigators: Oncology and the Impact on Outcomes

The projection of short- and long-term survival for. Conditional Survival Among Patients With Carcinoma of the Lung*

Optical Intra-operative Assessment of Breast Tumor Margins

Breast Screening: risks if you do and risks if you don t. Stephen W. Duffy Wolfson Institute of Preventive Medicine

NPQR Quality Payment Program (QPP) Measures 21_18247_LS.

LYMPHATIC DRAINAGE AXILLARY (MOSTLY) INTERNAL MAMMARY SUPRACLAVICULAR

Transcription:

Case Numbers and Process Quality in Breast Surgery in Germany Plenary of the European Commission Initiative on Breast Cancer (ECIBC): "Improving breast cancer screening, diagnosis and care in Europe" Lago Maggiore District, Italy, 10 December 2015 Priv.-Doz. Dr. med. Günther Heller

Agenda Introduction - Volume-Outcome-Relationships - Minimum Provider Volumes in Germany - Quality Assurance in Breast Surgery Breast Cancer Centers in Germany Case Numbers and Process Quality in Breast Surgery in Germany A look in the future / possible solutions a) mandatory quality assurance b) hospital planning using quality indicators c) minimum provider volumes d) oncologic (breast cancer) centers e) EU-Projects; EU-Guidelines 10.12.2015 Günther Heller 2

Introduction In recent decades, numerous studies have adressed outcome relationships in medical care provision Positive association between case numbers (per hospital; operation per surgeon) and the quality of medical care 10.12.2015 Günther Heller 3

Introduction Explanations for volume-outcome-relationships Greater experience and routine Better placed to provide the necessary multidisciplinary treatment and / or Better infrastructure In Germany, a minimum number of more than 100 primary cases per year is required for certified breast cancer centers at first certification Alternative explanation: High-Risk-Patients may increasingly attend smaller hospitals (which may be underestimated by risk adjustment methods) 10.12.2015 Günther Heller 4

Introduction In Germany federal laws postulated the introduction of minimum provider volumes for selected medical procedures (areas of medical care provision) by the joint federal committee (G-BA) 10.12.2015 Günther Heller 5

Introduction Minimum provider volumes for which medical procedures (areas of medical care provision)? - Liver Transplantation 20 / Year and Hospital - Kidney Transplantation 25 / Year and Hospital - Esophagus Surgery 10 / Year and Hospital - Stem Cell Transplantation 25 / Year and Hospital - Knee Joint Prostheses 50 / Year and Unit - VLBW (Level 1; < 1250g BW 14 / Year and Hospital 10.12.2015 Günther Heller 6

Introduction In Volume Outcome Analyses Mortality (Survival) => severe complication is frequently chosen as outcome measure High risk and low volume procedures of rare diseases are often analyzed 10.12.2015 Günther Heller 7

Introduction Breast Surgery following Breast Cancer High Volume in EU http://eu-cancer.iarc.fr/eucan/cancerone.aspx?cancer=46&gender=2 Low risk (short term outcome) Effect of recent health care quality may be difficult to describe 10.12.2015 Günther Heller 8

Objective/Aim To asses volume effects on the quality of health care provision in breast surgery, in Germany Using current data (up to date information) Entire health care setting Not only in specialized units or selective samples of patients but comprehensive perpective => Recent and Population based data 10.12.2015 Günther Heller 9

Patients and Methods Quality Assessment Programme ( 137 Social Code, Book V) Compulsory for inpatients with breast surgery, since 2002 Assessing Process Quality Indicators (adherence to guidelines) 2001-2009 Bundesgeschäftsstelle Qualitätssicherung 2010-2015 From 2016 Federal Institute for Quality Assurance and Transparency in Healthcare 10.12.2015 Günther Heller 10

Patients and Methods Further information referring to the mandatory quality assessment programme ( 137Social Code, Book V) => www.sqg.de 10.12.2015 Günther Heller 11

Patients and Methods Quality Survey (79 Items) Federal Expert Working Group 10.12.2015 Günther Heller 12

Patients and Methods Study Population Fully inpatients Admitted 2013/14, Discharged before 31.Jan. 2015 First surgical procedure for a primary tumor Histology: invasive breast cancer ductal carcinoma in situ (DCIS) 10.12.2015 Günther Heller 13

Patients and Methods hospital volume (categories) 10.12.2015 Günther Heller 14

Patients and Methods 10.12.2015 Günther Heller 15

Patients and Methods 10.12.2015 Günther Heller 16

Patients and Methods 10.12.2015 Günther Heller 17

Patients and Methods Process Indicators => no risk adjustment necessary Subgroup analyses (1) Patients younger than 65 years ASA1 or ASA2 pn0 node status pt0 or pt1, according to the TNM classification Quality Indicators 1, 2, 5-7 10.12.2015 Günther Heller 18

Patients and Methods Subgroup analyses (2) Patients younger than 65 years ASA1 or ASA2 (pn0 node status pt0 or pt1) Tumor size smaller than 5 cm Indicators 3,4 (DCIS) 10.12.2015 Günther Heller 19

Patients and Methods Statistical Methods Means per Volume Category (95% Confidence Intervals) Scatter Plots and Lowess Regression (Cleveland 1979) (Rogowski et al.: JAMA 2004) 10.12.2015 Günther Heller 20

Results 10.12.2015 Günther Heller 21

Results 10.12.2015 Günther Heller 22

Results 10.12.2015 Günther Heller 23

Results 10.12.2015 Günther Heller 24

Results 10.12.2015 Günther Heller 25

Results 10.12.2015 Günther Heller 26

Discussion Better quality of care in hospitals with larger numbers Not consistently steady Worst results in lowest case number category Subgproup analyses => results can not be explained with sicker patients in smaller hospitals Longer intervals to operations => histological confirmation => treatment capacities in large centers exhausted => more patients from mammographic screening programs However, no optimal interval between treatment and surgery is defined according to guidelines 10.12.2015 Günther Heller 27

Discussion Our results show considerable variation of process quality within Germany in recent years Smaller (more remote) units perform worse than larger units (breast cancer centers) Possible Solutions: mandatory quality assurance minimum provider volumes quality-orientated hospital planning restriction of treatment to breast cancer centers EU-Projects; EU-Guidelines 10.12.2015 Günther Heller 28

Reference 10.12.2015 Günther Heller 29

Thank You for your attention! Priv.-Doz. Dr. med. Günther Heller Institut für Qualitätssicherung und Transparenz im Gesundheitswesen Katharina-Heinroth-Ufer 1 10787 Berlin Tel. 030 585826-0 guenther.heller@iqtig.org www.iqtig.org 10.12.2015 Günther Heller 30